Evidence map›Paper›PMID 32139767›Full record

ArticleScientific reports2020

Genotypic characterization of multiple drug resistant Escherichia coli isolates from a pediatric cancer hospital in Egypt.

Reem Hassan, Marwa Tantawy, Nouran A Gouda, Mariam G Elzayat, Sara Gabra, Amena Nabih, Aya A Diab, Mohamed El-Hadidi, Usama Bakry, Mohamed R Shoeb and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Genotypic Patterns of Multidrug-ResistantAdvanced biomedical research · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Occurrence and Antimicrobial Resistance Traits ofInternational journal of environmental research and public health · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Reem HassanMolecular Microbiology Unit, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Marwa TantawyGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Nouran A GoudaGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Mariam G ElzayatGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Sara GabraGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Amena NabihGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Aya A DiabGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Mohamed El-HadidiBioinformatics Group, Center of Informatics Sciences (CIS), Nile University, Giza, Egypt.
Usama BakryGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Mohamed R ShoebGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Mervat ElananyDepartment of clinical pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Lobna ShalabyInfectious disease unit, Children's cancer hospital Egypt 57357, Cairo, Egypt.
Ahmed A SayedGenomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt. ahmad.sayed@57357.org.
Children Cancer Hospital · EGCairo University · EGAin Shams University · EGNile University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with multiple drug resistant (MDR) Escherichia coli poses a life threat to immunocompromised pediatric cancer patients. Our aim is to genotypically characterize the plasmids harbored in MDR E. coli isolates recovered from bacteremic patients of Children's Cancer Hospital in Egypt 57357 (CCHE 57357). In this study, 21 carbapenem-resistant E. coli (CRE) isolates were selected that exhibit Quinolones and Aminoglycosides resistance. Plasmid shot-gun sequencing was performed using Illumina next- generation sequencing platform. Isolates demonstrated resistant to all beta-lactams, carbapenems, aminoglycosides and quinolones. Of the 32 antimicrobial resistant genes identified that exceeded the analysis cutoff coverage, the highest represented genes were aph(6)-Id, sul2, aph(3″)-Ib, aph(3')-Ia, sul1, dfrA12, TEM-220, NDM-11. Isolates employed a wide array of resistance mechanisms including antibiotic efflux, antibiotic inactivation, antibiotic target replacements and antibiotic target alteration. Sequenced isolates displayed diverse insertion sequences, including IS26, suggesting dynamic reshuffling of the harbored plasmids. Most isolates carried plasmids originating from other bacterial species suggesting a possible horizontal gene transfer. Only two isolates showed virulence factors with iroA gene cluster which was found in only one of them. Outside the realms of nosocomial infections among patients in hospitals, our results indicate a transfer of resistant genes and plasmids across different organisms.

Indexed as

Anti-Bacterial AgentsCancer Care FacilitiesDrug Resistance, Multiple, BacterialEgyptEscherichia coliEscherichia coli ProteinsGenotypeHumansMicrobial Sensitivity TestsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnti-Bacterial AgentsEscherichia coli Proteins

Identifiers

PMID32139767
PMCPMC7057982
OpenAlexW3009166088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.